secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDICINOVA INC (MNOV)
CIK:        0001226616
Form:       8-K
Filed at:   2023-06-22T23:59:59+00:00
Accession:  0001193125-23-172585
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

MediciNova receives two Nasdaq deficiency notices for board and audit committee independence
--------------------------------------------------------------------------------

- Received Audit Committee Notice on June 15, 2023 due to committee having two independent members instead of three.
- Received Independent Board Notice on June 22, 2023 for having only two independent directors out of five board seats.
- Cure period: until the earlier of next annual meeting or June 13, 2024 (or Dec 11, 2023 if meeting before then).
- Company plans to appoint an additional independent director; no immediate impact on stock listing or trading.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1226616/000119312523172585/0001193125-23-172585-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1226616/000119312523172585/d512906d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-172585

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer